Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/VAXART-INC-40834288/news/Vaxart-Inc-gibt-bekannt-dass-der-letzte-Proband-in-der-Phase-1-Studie-mit-dem-Norovirus-Impfstoff-45618258/?utm_source=whatsapp&utm_medium=social&utm_campaign=share